| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO, Anheart Therapeutics Ltd.
1 company
Wang Junyuan Jerry is a CEO, Anheart Therapeutics Ltd. at Nuvation Bio Inc.. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $18.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | NUVB Nuvation Bio Inc. | CEO, Anheart Therapeutics Ltd. | Sell | 56,361 | $2.89 | $162,883.29 | -1.4% | -24.3% | +65.4% |